Immunotherapy, Radiation Do Not Increase Necrosis in NSCLC Brain Tumors

Immune checkpoint inhibitors and stereotactic radiosurgery do not increase the risk of necrosis among patients with NSCLC who have brain metastases, according to research.

Related Keywords

United States ,Miami ,Florida ,American , ,American Lung Association ,American Cancer Society ,Fernandez Family Foundation ,Cancer Research At Miami Institute ,International Radiosurgery Research Foundation ,Baptist Health South Florida ,Fernandez Family Foundation Endowed Chair ,Cancer Research ,Miami Cancer Institute ,Applied Clinical Medical Physics ,Tecentriq Plus Chemo Improves ,Non Small Cell Lung Cancer With Brain ,American Cancer ,Tremendous Hope Surrounds Emerging Therapies ,Cancer That ,Lung Cancer ,